EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease

Asuka Morizane, Emi Yamasaki, Takero Shindo, Takayuki Anazawa, Nobukatsu Sawamoto, Atsushi Shima, Hodaka Yamakado, Etsuro Nakanishi, Masanori Sawamura, Yosuke Taruno, Daisuke Doi, Tetsuhiro Kikuchi und 8 weitere

Cell Stem Cell · 2025-09 · 32 (9) · 1346-1355.e3

DOI: 10.1016/j.stem.2025.07.012 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Cell Stem Cell, 2025-09. Verfasst von Asuka Morizane und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan; Center for Clini…. Hauptthemen laut MEDLINE: Parkinson Disease, Induced Pluripotent Stem Cells, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseInduced Pluripotent Stem CellsCell- and Tissue-Based TherapyHumansTransplantation, HomologousHLA AntigensMaleDendritic CellsMiddle AgedCell DifferentiationFemaleDopaminergic Neurons

Stichwörter der Autor:innen

Parkinson’s diseasecell therapyclinical trialgrafthuman leukocyte antigenimmune rejectioninduced pluripotent stem cellpositron emission tomographytransplantation

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan; Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital…
  • Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
  • Department of Hematology/Oncology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
  • Department of Surgery, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
  • Department of Neurology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
  • Departmnt of Neurosurgery, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Morizane, A., Yamasaki, E., Shindo, T., Anazawa, T., Sawamoto, N., Shima, A., Yamakado, H., Nakanishi, E., Sawamura, M., Taruno, Y., Doi, D., Kikuchi, T., Kawasaki, Y., Saito, M. K., Kikuchi, T., Arakawa, Y., Miyamoto, S., Nakamoto, Y., Takahashi, R., & Takahashi, J. (2025). Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease. Cell Stem Cell, 32(9), 1346-1355.e3. https://doi.org/10.1016/j.stem.2025.07.012

Vancouver

Morizane A, Yamasaki E, Shindo T, Anazawa T, Sawamoto N, Shima A, et al. Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease. Cell Stem Cell. 2025;32(9):1346-1355.e3. doi:10.1016/j.stem.2025.07.012

BibTeX
@article{Morizane2025,
  author = {Morizane, Asuka and Yamasaki, Emi and Shindo, Takero and Anazawa, Takayuki and Sawamoto, Nobukatsu and Shima, Atsushi and Yamakado, Hodaka and Nakanishi, Etsuro and Sawamura, Masanori and Taruno, Yosuke and Doi, Daisuke and Kikuchi, Tetsuhiro and Kawasaki, Yuri and Saito, Megumu K and Kikuchi, Takayuki and Arakawa, Yoshiki and Miyamoto, Susumu and Nakamoto, Yuji and Takahashi, Ryosuke and Takahashi, Jun},
  title = {Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease},
  journal = {Cell Stem Cell},
  year = {2025},
  volume = {32},
  number = {9},
  pages = {1346--1355.e3},
  doi = {10.1016/j.stem.2025.07.012}
}
Kostenlos starten →